MEDICANESTH: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDICANESTH
Largest movements
- Receivables within one year +€33,544
up €33,544 (+28.3%), from €118,340 to €151,884
of which Other amounts receivable: +€40,999
- Cash +€26,233
up €26,233 (+21.7%), from €120,683 to €146,916
mainly Net result for the year (+€95,986) and Other debts (+€62,421)
- Intangible fixed assets -€21,000
down €21,000 (-15.3%), from €137,277 to €116,277
- Current investments +€18,239
up €18,239 (+33.7%), from €54,057 to €72,296
- Tangible fixed assets -€8,394
down €8,394 (-26.3%), from €31,967 to €23,573
- Reserves +€84,199
up €84,199 (+55.7%), from €151,296 to €235,495
of which Tax-exempt reserves: +€84,200
- Other debts +€62,421
new in 2025: €62,421
- Tax, wage and social debts -€53,211
no longer reported in 2025 (was €53,211)
- Debts after one year -€38,293
down €38,293 (-35.5%), from €107,779 to €69,486
- Trade debts -€17,009
down €17,009 (-92.1%), from €18,475 to €1,466
- Gross operating margin -€127,921
down €127,921 (-34.6%), from €369,398 to €241,477
- Taxes -€29,976
down €29,976 (-51.5%), from €58,156 to €28,180
- Financial charges -€21,751
down €21,751 (-20.0%), from €108,587 to €86,836
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €464,456 | €514,799 | +€50,343 | +10.8% |
| Fixed assets | 21/28 | €169,244 | €139,850 | -€29,394 | -17.4% |
| Intangible fixed assets | 21 | €137,277 | €116,277 | -€21,000 | -15.3% |
| Tangible fixed assets | 22/27 | €31,967 | €23,573 | -€8,394 | -26.3% |
| Furniture and vehicles | 24 | €31,967 | €23,573 | -€8,394 | -26.3% |
| Current assets | 29/58 | €295,212 | €374,949 | +€79,737 | +27.0% |
| Amounts receivable within one year | 40/41 | €118,340 | €151,884 | +€33,544 | +28.3% |
| Trade receivables | 40 | €73,436 | €65,980 | -€7,456 | -10.2% |
| Other amounts receivable | 41 | €44,904 | €85,903 | +€40,999 | +91.3% |
| Current investments | 50/53 | €54,057 | €72,296 | +€18,239 | +33.7% |
| Cash at bank and in hand | 54/58 | €120,683 | €146,916 | +€26,233 | +21.7% |
| Deferred charges and accrued income | 490/1 | €2,132 | €3,853 | +€1,721 | +80.7% |
| Total equity and liabilities | 10/49 | €464,456 | €514,799 | +€50,343 | +10.8% |
| Equity | 10/15 | €247,148 | €343,133 | +€95,985 | +38.8% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €151,296 | €235,495 | +€84,199 | +55.7% |
| Tax-exempt reserves | 132 | - | €84,200 | +€84,200 | |
| Distributable reserves | 133 | €151,296 | €151,295 | -€1 | 0.0% |
| Profit (loss) carried forward | 14 | €93,852 | €105,637 | +€11,785 | +12.6% |
| Amounts payable | 17/49 | €217,308 | €171,666 | -€45,642 | -21.0% |
| Amounts payable after more than one year | 17 | €107,779 | €69,486 | -€38,293 | -35.5% |
| Financial debts | 170/4 | €107,779 | €69,486 | -€38,293 | -35.5% |
| Amounts payable within one year | 42/48 | €109,529 | €102,180 | -€7,349 | -6.7% |
| Current portion of amounts payable after more than one year | 42 | €37,843 | €38,293 | +€450 | +1.2% |
| Trade debts | 44 | €18,475 | €1,466 | -€17,009 | -92.1% |
| Suppliers | 440/4 | €18,475 | €1,466 | -€17,009 | -92.1% |
| Taxes, remuneration and social security | 45 | €53,211 | - | -€53,211 | |
| Taxes | 450/3 | €53,211 | - | -€53,211 | |
| Other amounts payable | 47/48 | - | €62,421 | +€62,421 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €31,131 | €30,492 | -€639 | -2.1% |
| Other operating charges | 640/8 | €126 | €761 | +€635 | +504% |
| Gross operating margin | 9900 | €369,398 | €241,477 | -€127,921 | -34.6% |
| Operating profit (loss) | 9901 | €338,141 | €210,223 | -€127,918 | -37.8% |
| Financial income | 75/76B | €721 | €779 | +€58 | +8.0% |
| Recurring financial income | 75 | €721 | €779 | +€58 | +8.0% |
| Financial charges | 65/66B | €108,587 | €86,836 | -€21,751 | -20.0% |
| Recurring financial charges | 65 | €108,587 | €86,836 | -€21,751 | -20.0% |
| Profit (loss) for the period before taxes | 9903 | €230,275 | €124,166 | -€106,109 | -46.1% |
| Income taxes | 67/77 | €58,156 | €28,180 | -€29,976 | -51.5% |
| Profit (loss) for the period | 9904 | €172,119 | €95,986 | -€76,133 | -44.2% |
| Transfer to tax-exempt reserves | 689 | - | €84,200 | +€84,200 | |
| Profit (loss) for the period to be appropriated | 9905 | €172,119 | €11,786 | -€160,333 | -93.2% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.